Diamonds and Dogs

10/7/20

Eli Lilly (LLY) is up 2% after releasing positive interim clinical trial data for its Covid-19 treatment. Lilly is also going to submit an initial request for an emergency use authorization of the drug. Last week, Regeneron also reported positive early data on the Covid-19 treatment which was also used on the President of the United States.

Luminex (LMNX) trading lower. The biological testing technology company is down 6% after lifting preliminary third quarter sales. The company expects revenues of approximately $106 million, up approximately 35% as demand for their COVID-19-related products continue to outstrip their ability to supply the products. The stock is stuck in a trading range.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.